New Covid cases may peak today, say experts

NEW DELHI: Scientists working on a mathematical model to chart the trajectory of Covid-19 cases have noted that the peak of new infections could be reached within the next 24 hours at around 4 lakh cases (seven-day average) and peak of active caseload could touch around 40 lakh between May 14-18.

“Our model shows that the peak of new cases, taken as 7-day average, will be reached by Tuesday and the peak of active infections would be around 40 lakh at lower end of our earlier prediction range,” Manindra Agrawal of IIT-Kanpur told TOI on Monday while sticking to last week’s observation

The model, called SUTRA, had on April 25 predicted peak value of new infections between 3.4 to 4.4 lakh during May 4-8 and peak value of active infections between 38-48 lakh during May 14-18. “We have been consistent since then,” said Agrawal, flagging possibility of lower end of the observed range.

He also said third wave of the pandemic was unlikely, adding an important caveat that vaccination needs to pick up speed and that people do not abandon safe behaviour again.

“If as planned, 40% of the population would be vaccinated by October. Besides, a huge percentage of people would already be infected by then. So even if the third wave comes, it won’t be like what we have been experiencing now,” said Agrawal.

Besides Agrawal, two other scientists – Madhuri Kanitkar, deputy chief, Integrated Defence Staff, and M Vidyasagar of IIT-Hyderabad – have been working on the SUTRA model. They have been working closely with the government.

“While we could not predict the exact nature of the second wave earlier, we continue our efforts to better estimate its future trajectory,” they said in a joint statement while explaining why their initial prediction that the second wave will peak by the third week of April and log around 1 lakh daily cases went wrong.

  • Related Posts

    Cancer cure must not be hostage to Big Pharma

    In recent years, immunotherapy has expanded the limits of cancer treatment. Therapies that harness the body’s immune system to fight malignant cells have improved survival rates in cancers once considered…

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Pune:- A woman, 34, dia­gnosed with poly­cystic ovary syn­drome, or PCOS, as a teen­ager, saw her first nat­ural men­strual cycle in Feb­ru­ary—six months after start­ing Moun­jaro for weight man­age­ment. This…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Cancer cure must not be hostage to Big Pharma

    Cancer cure must not be hostage to Big Pharma

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    GLP-1 drugs emerge as a new option for Indian women bat­tling PCOS

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Aurobindo Pharma gains after receving USFDA nod for Glycerol Phenylbutyrate Oral Liquid

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Legal Loopholes Stall Crackdown On Interstate Fake Drug Rackets In India

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    Patna HC Rules Phenothiazine & Promethazine Not Narcotic Or Psychotropic Substances Under NDPS Act

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients

    COMT Inhibitors May Fuel Gut Bacteria That Degrade Levodopa In Parkinson’s Patients